BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2894293)

  • 1. Quazepam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia.
    Ankier SI; Goa KL
    Drugs; 1988 Jan; 35(1):42-62. PubMed ID: 2894293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quazepam: hypnotic efficacy and side effects.
    Kales A
    Pharmacotherapy; 1990; 10(1):1-10; discussion 10-2. PubMed ID: 1969151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quazepam and flurazepam: differential pharmacokinetic and pharmacodynamic characteristics.
    Hilbert JM; Battista D
    J Clin Psychiatry; 1991 Sep; 52 Suppl():21-6. PubMed ID: 1680120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam.
    Kales A; Bixler EO; Vela-Bueno A; Soldatos CR; Niklaus DE; Manfredi RL
    Clin Pharmacol Ther; 1986 Oct; 40(4):378-86. PubMed ID: 3530586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loprazolam. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in insomnia.
    Clark BG; Jue SG; Dawson GW; Ward A
    Drugs; 1986 Jun; 31(6):500-16. PubMed ID: 2874007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quazepam and flurazepam: long-term use and extended withdrawal.
    Kales A; Bixler EO; Soldatos CR; Vela-Bueno A; Jacoby J; Kales JD
    Clin Pharmacol Ther; 1982 Dec; 32(6):781-8. PubMed ID: 7140142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative 25-night sleep laboratory study on the effects of quazepam and triazolam on chronic insomniacs.
    Mamelak M; Csima A; Price V
    J Clin Pharmacol; 1984; 24(2-3):65-75. PubMed ID: 6143767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal.
    Kales A; Bixler EO; Soldatos CR; Vela-Bueno A; Jacoby JA; Kales JD
    Clin Pharmacol Ther; 1986 Mar; 39(3):345-52. PubMed ID: 2868823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
    Scharf MB
    J Clin Psychiatry; 1993 Jan; 54(1):33-8. PubMed ID: 8428895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective measurements of daytime sleepiness and performance comparing quazepam with flurazepam in two adult populations using the Multiple Sleep Latency Test.
    Dement WC
    J Clin Psychiatry; 1991 Sep; 52 Suppl():31-7. PubMed ID: 1680123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects.
    Kales A; Kales JD
    J Clin Psychopharmacol; 1983 Apr; 3(2):140-50. PubMed ID: 6132933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early morning insomnia with rapidly eliminated benzodiazepines.
    Kales A; Soldatos CR; Bixler EO; Kales JD
    Science; 1983 Apr; 220(4592):95-7. PubMed ID: 6131538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.
    Soldatos CR; Dikeos DG; Whitehead A
    Int Clin Psychopharmacol; 1999 Sep; 14(5):287-303. PubMed ID: 10529072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quazepam versus triazolam in patients with sleep disorders: a double-blind study.
    Mauri MC; Gianetti S; Pugnetti L; Altamura AC
    Int J Clin Pharmacol Res; 1993; 13(3):173-7. PubMed ID: 7901174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebound insomnia: a critical review.
    Gillin JC; Spinweber CL; Johnson LC
    J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute effect of quazepam on the sleep of chronic insomniacs. A dose-response study.
    Tietz EI; Roth T; Zorick FJ; Piccione P; Kramer M
    Arzneimittelforschung; 1981; 31(11):1963-6. PubMed ID: 6119098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insomnia: drug treatment.
    Tsoi WF
    Ann Acad Med Singap; 1991 Mar; 20(2):269-72. PubMed ID: 1679317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the short-term treatment of insomnia in out-patients with 15 milligrams of quazepam.
    Mendels J; Stern S
    J Int Med Res; 1983; 11(3):155-61. PubMed ID: 6347747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quazepam in the short-term treatment of insomnia in outpatients.
    Aden GC; Thatcher C
    J Clin Psychiatry; 1983 Dec; 44(12):454-6. PubMed ID: 6361006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.